{Reference Type}: Journal Article
{Title}: NICE guideline on ME/CFS: robust advice based on a thorough review of the evidence.
{Author}: Barry PW;Kelley K;Tan T;Finlay I;
{Journal}: J Neurol Neurosurg Psychiatry
{Volume}: 95
{Issue}: 7
{Year}: 2024 Jun 17
{Factor}: 13.654
{DOI}: 10.1136/jnnp-2023-332731
{Abstract}: In 2021, the National Institute for Health and Care Excellence produced an evidence-based guideline on the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a disabling long-term condition of unknown cause. The guideline provides clear support for people living with ME/CFS, their families and carers, and for clinicians. A recent opinion piece published in the journal suggested that there were anomalies in the processing and interpretation of the evidence when developing the guideline and proposed eight areas where these anomalies were thought to have occurred. We outline how these opinions are based on a misreading or misunderstanding of the guideline process or the guideline, which provides a balanced and reasoned approach to the diagnosis and management of this challenging condition.